TET1 promotes fatty acid oxidation and inhibits NAFLD progression by hydroxymethylation of PPARα promoter

被引:0
|
作者
Jingjie Wang
Yitong Zhang
Qin Zhuo
Yujen Tseng
Jiucun Wang
Yanyun Ma
Jun Zhang
Jie Liu
机构
[1] Fudan University,Department of Digestive Diseases of Huashan Hospital and Institutes of Biomedical Sciences
[2] Human Phenome Institute,State Key Laboratory of Genetic Engineering
[3] Fudan University,undefined
[4] Six-sector Industrial Research Institute,undefined
[5] Fudan University,undefined
来源
关键词
TET1; NAFLD; PPARα; Fatty acid oxidation; Hydroxymethylation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] TET1 promotes fatty acid oxidation and inhibits NAFLD progression by hydroxymethylation of PPARα promoter
    Wang, Jingjie
    Zhang, Yitong
    Zhuo, Qin
    Tseng, Yujen
    Wang, Jiucun
    Ma, Yanyun
    Zhang, Jun
    Liu, Jie
    NUTRITION & METABOLISM, 2020, 17 (01)
  • [2] Downregulation of TET1 Promotes Bladder Cancer Cell Proliferation and Invasion by Reducing DNA Hydroxymethylation of AJAP1
    Yan, Yi-lin
    Huang, Zheng-nan
    Zhu, Zhen
    Cui, Yang-yan
    Li, Mei-qian
    Huang, Rui-min
    Yan, Jun
    Shen, Bing
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [3] TET1 PROMOTES TUMOR PROGRESSION OF CHOLANGIOCARCINOMA WITH WILD-TYPE IDH1.
    Bai, Xuewei
    Zhang, Hongyu
    Zhou, Yamei
    Sun, Bei
    Ji, Chengcheng
    Nagaoka, Katsuya
    Cao, Kevin
    Cheng, Zhixiang
    Mueller, William
    Lu, Shaolei
    Wands, Jack R.
    Huang, Chiung-kuei
    HEPATOLOGY, 2019, 70 : 1187A - 1187A
  • [4] TET1 promotes cisplatin-resistance via demethylating the vimentin promoter in ovarian cancer
    Han, Xi
    Zhou, Yuanyuan
    You, Yuanyi
    Lu, Jiaojiao
    Wang, Lijie
    Hou, Huilian
    Li, Jing
    Chen, Wei
    Zhao, Le
    Li, Xu
    CELL BIOLOGY INTERNATIONAL, 2017, 41 (04) : 405 - 414
  • [5] Macrophage fatty acid oxidation inhibits atherosclerosis progression
    Nomura, Mitsunori
    Liu, Jie
    Yu, Zu-Xi
    Yamazaki, Tomoko
    Yan, Ye
    Kawagishi, Hiroyuki
    Rovira, Ilsa I.
    Liu, Chengyu
    Wolfgang, Michael J.
    Mukouyama, Yoh-suke
    Finkel, Toren
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2019, 127 : 270 - 276
  • [6] miR-30a as Potential Therapeutics by Targeting TET1 through Regulation of Drp-1 Promoter Hydroxymethylation in Idiopathic Pulmonary Fibrosis
    Zhang, Songzi
    Liu, Huizhu
    Liu, Yuxia
    Zhang, Jie
    Li, Hongbo
    Liu, Weili
    Cao, Guohong
    Xv, Pan
    Zhang, Jinjin
    Lv, Changjun
    Song, Xiaodong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (03):
  • [7] Lipotoxicity-Induced TET1 Mediates CD36 DNA Demethylation in Liver Macrophages to Aggravate NAFLD Progression
    Yu, Piaojian
    Xian, Yingxin
    Cao, Huanyi
    Deng, Xiaojie
    Cai, Mengyin
    Xu, Fen
    DIABETES, 2024, 73
  • [8] KNOCKOUT OF TET1 ALLEVIATES NON-ALCOHOLIC FATTY LIVER DISEASE PROGRESSION BY TARGETING LIPID METABOLISM
    Huang, Chiung-Kuei
    HEPATOLOGY, 2021, 74 : 1075A - 1075A
  • [9] PPARγ1 stimulates uptake and oxidation of fatty acid in myocytes
    Yao, Jianrong
    Hu, Shanming
    Kahn, C. R.
    Spector, Arthur A.
    Norris, Andrew W.
    DIABETES, 2007, 56 : A399 - A399
  • [10] miR-646/TET1 mediated demethylation of IRX1 promoter upregulates HIST2H2BE and promotes the progression of invasive ductal carcinoma
    He, Baoxia
    Chen, Jinhua
    Song, Wenping
    Bai, Yongtao
    GENOMICS, 2021, 113 (03) : 1469 - 1481